- Opko Health (OPK) plans to register its shares on the Tel Aviv Stock Exchange as part of its $540M acquisition of Israeli drugmaker Prolor Biotech.
- The move, which will add to Opko's listing on the NYSE, will enable the company to pay for the purchase with locally listed stock.
- Opko's shares will start trading on the TASE on Wednesday. In October, the stock will enter the Tel Aviv 25 index of bluechip shares. (PR)